
Dr Alfredo Iacoangeli
Research Fellow in Translational Bioinformatics
- Phone
- Email
- Website
-
KCL Purehttps://kclpure.kcl.ac.uk/portal/alfredo.iacoangeli.html
-
ORCID iDhttps://orcid.org/0000-0002-5280-5017
-
Google Scholarhttps://scholar.google.com/citations?user=g410uocAAAAJ
BIOGRAPHY
After a career in Biophysics, Dr. Alfredo Iacoangeli accepted his PhD “cum laude” in Life Sciences in January 2016 from “Sapienza” University of Rome where he worked on structural bioinformatics with a particular focus on protein structure prediction and protein-peptide interaction. He joined King’s College London in March 2016 and he is now the Bioinformatics lead of a joint project between the Department of Basic and Clinical Neuroscience and the Health Informatics Unit at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. The aim of this project is twofold: 1) the development of a high throughput gene, environment and epigenetics database and analysis system for international MND/ALS research; 2) the use of large multi-omics datasets to identify subgroups MND/ALS patients with homogeneous disease causes and clinical phenotype, and to gain new insights into the disease pathogenesis. Dr. Iacoangeli is first author of several scientific articles in the field of Structural and Genomic Bioinformatics and MND/ALS genetics.
RESEARCH INTERESTS
Bioinformatics (both genomics and structural biology); Genetics of complex diseases; Big Biodata; Precision medicine; Machine learning.
LATEST PUBLICATIONS
- GEOexplorer: a webserver for gene expression analysis and visualisation
- Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3'UTR protect against ALS
- Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
- Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
- Enrichment of sarm1 alleles encoding variants with constitutively hyperactive nadase in patients with als and other motor nerve disorders